Portfolio company
Probably Genetic
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company provides genetic testing and diagnostic tools to help patients with undiagnosed rare diseases access clinical trials and treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sano Genetics
This company provides a software platform connecting patients with chronic conditions to pharmaceutical researchers for precision medicine clinical trials and genetic testing.
myTomorrows
This company provides a platform for clinical trial recruitment and expanded access management to support patients, healthcare professionals and biopharmaceutical firms.
Centogene
This company provides genetic diagnostic tests and data-driven medical solutions for rare disease patients, healthcare providers, and pharmaceutical partners.
Power
This company provides an open-access digital platform for patients to discover and access clinical trial studies across various medical conditions.
Findmecure
This company provides a search platform for clinical trials to help patients discover and understand medical treatments currently in development.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
VUS Genetics
This company develops high-throughput functional assays for drug developers to classify gene variants and improve patient stratification in oncology and rare disease clinical trials.
3X Genetics
This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.
